Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-28 @ 2:47 AM
Study NCT ID:
NCT05931757
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-07-05
First Post:
2023-06-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-16
First Submit QC Date:
None
Study First Post Date:
2023-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-01
Last Update Post Date:
2023-07-05
Last Update Post Date Type:
ACTUAL